Investments in Australia’s health squarely on election agenda

Pharma trade group Medicines Australia has welcomed the government’s announcement of an increase in its investment in the health the nation. Similarly, it acknowledged the Opposition’s matching of these announcements in recognition of the need for additional investment in health.

“Strengthening Medicare, investments in precision medicines, onshore manufacturing of IV fluids and assisting Australians to access healthcare as they juggle cost of living pressures through initiatives including a reduced co-payment for access to medicines on the PBS is very welcome,” said Liz de Somer, chief executive of Medicines Australia.

“We are pleased with the government’s commitment of A$1.8 billion (US$1.13 billion) to the Pharmaceutical Benefits Scheme (PBS) and the listing of new medicines within this budget.